Akari Therapeutics, Plc (AKTX) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Akari Therapeutics (AKTX) moliyalashtirish dinamikasi kamyob kasalliklar uchun dori-darmon sinovlari natijalariga bog'liq. Joriy uzoq muddatli qarzdorlikning kapitalga nisbati ushbu aktivlar o'zgarishlarini aks ettiradi va 0.00 qiymati ushbu ko'rsatkichni ifodalaydi. O'sish FDA ning qat'iy nazorati va patentlar bilan cheklangan. Rivojlanish strategiyasi makroiqtisodiy holatlardan mustaqil bo'lgan, izolyatsiyalangan biotexnologiya sikli doirasidagi birlashmalarga asoslangan.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_AKTX_-_Akari-Therapeutics_-_Long-Term-Debt-to-Capital "AKTX: Akari Therapeutics Plc Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 01.11.2026 | 👁️GURU.Markets👁️")
Akari Therapeutics (AKTX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Akari Therapeutics|AKTX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati akaritx.com|AKTX - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Akari Therapeutics Plc|AKTX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Akari Therapeutics|Tezkor likvidlik ko‘rsatkichi akaritx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Akari Therapeutics PLC - AKTX
Uzoq muddatli qarzdorlikning kapitalga nisbati koeffitsiyenti bir yildan ortiq muddatga ega majburiyatlarning aksiyadorlar kapitaliga nisbatan ulushini o'lchaydi. Ushbu hisob-kitob bozor shovqinlarini filtrlash orqali moliyaviy barqarorlikdagi haqiqiy o'zgarishlarni ochib beradi. Uzoq muddatli qarzdorlikning kapitalga nisbati tarixini tahlil qilish orqali investor Akari Therapeutics (AKTX) kompaniyasining birlashish strategiyalarining ta'sirini ko'rishi mumkin. Izolyatsiyalangan biotexnologiya sikli doirasida ushbu ko'rsatkich kompaniyaning kamyob kasalliklar bo'yicha sinovlarini moliyalashtirish qobiliyatini belgilaydi. Makro muhitga bog'liqlikning pastligi ushbu metrikani biznesning uzoq muddatli to'lov qobiliyatini baholash uchun asosiy vositaga aylantiradi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Septerna Corp - Uzoq muddatli qarzning kapitalga nisbati|PVLA - Uzoq muddatli qarzning kapitalga nisbati|Savara Inc. (SVRA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|rigel.com (RIGL) - Uzoq muddatli qarzning kapitalga nisbati|ANAB (AnaptysBio) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Astria Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati enGene Bio (ENGN)|RAPT (rapt.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati JBIO (Aerovate Therapeutics)|Uzoq muddatli qarzdorlikning kapitalga nisbati aclaristx.com (ACRS)|KYTX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TLSA (Tiziana Life Sciences Ltd.)|CABA (Cabaletta Bio, Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|VTYX: Uzoq muddatli kreditlarning kapitalga nisbati|THTX (Theratechnologies Inc.) - Uzoq muddatli qarzning kapitalga nisbati|AVTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ELDN|AGEN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Climb Bio, Inc. CLYM|Uzoq muddatli qarzning kapitalga koeffitsiyenti ZURA|aTyr Pharma, Inc. - Uzoq muddatli qarzning kapitalga nisbati|ADAG - Uzoq muddatli qarzning kapitalga nisbati|ikenaoncology.com (IMA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati STTK (Shattuck Labs)|EQ (Equillium Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Connect Pharma CNTB|Uzoq muddatli qarzning o'z kapitaliga nisbati IMUX (Immunic, Inc.)|Uzoq muddatli qarzning kapitalga nisbati atarabio.com (ATRA)|InflaRx - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati XFOR (X4 Pharmaceuticals Inc.)|Adicet - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Celularity Inc. CELU|INMB: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati barinthusbio.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Kezar Life Sciences, Inc.|SAB Biotherapeutics Inc. (SABS) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ENLV|Uzoq muddatli qarzning kapitalga nisbati q32bio.com (QTTB)|Uzoq muddatli qarzning o'z kapitaliga nisbati GeoVax Labs, Inc. GOVX|Uzoq muddatli qarzning kapitalga nisbati edesabiotech.com EDSA|IBIO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Carisma Therapeutics - Uzoq muddatli kreditlarning kapitalga nisbati|XTLB (XTL Biopharmaceuticals, Ltd.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BOLT|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|Aptevo - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati AIM|ADTX (aditxt.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|Uzoq muddatli qarzning kapitalga nisbati XORTX Corp XRTX|HIND - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti REVB (revbiosciences.com)|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Scinai Immunotherapeutics Ltd|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Affimed Therapeutics|Uzoq muddatli qarzning o'z kapitaliga nisbati ALLK (Allakos Inc.)|HOOK (hookipapharma.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzdorlikning kapitalga nisbati iTeos Therapeutics Inc (ITOS)|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|TC BioPharm Ltd (TCBP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati